TLR10 and COVID-19: With the ability to suppress the expression of proinflammatory cytokines and chemokines, regulation of TLR10 may be a promising approach to balance the inflammatory response in respiratory diseases, including in severe cases of COVID-19, in which a cytokine storm can cause organ damage [51,52].